Sustainability leadership NeoVac positions itself as a leading full-service provider for intelligent, resource-efficient energy and water usage and storage, suggesting potential partnerships or sales of sustainability optimization solutions, monitoring, and data analytics offerings.

RNA vaccine focus Recent news indicates NeoVac is developing RNA vaccines and a proprietary lipid nanoparticle platform, presenting opportunities for collaboration on biotech manufacturing support, data infrastructure, and regulated product development tooling.

PRD collaboration NeoVac has engaged in process research development with Aragen since late 2021, implying openness to external R&D partnerships and outsourced process optimization services, as well as scalable pilot and tech transfer capabilities.

Tech stack leverage With a modern tech stack (Power BI, SQL Server, Azure DevOps, SonarQube, Dynamics, 365), there is opportunity to offer integration, data science, and DevOps services to enhance operational efficiency and decision-making across energy and water solutions.

Mid-market growth Revenue in the $1M-$10M range and 200+ employees suggest NeoVac is a growing mid-market customer with potential needs in enterprise software licenses, cloud-based analytics, ERP optimization, and scalable training or SaaS solutions.